Zobrazeno 61 - 70
of 379
pro vyhledávání: ''
Autor:
Jacopo Giuliani, Andrea Bonetti
Publikováno v:
Tumori Journal. 101:347-352
Introduction The treatment of patients with metastatic breast cancer (mBC) is one of the most difficult problems in clinical oncology. Clinical trial results suggest that novel therapies may be having a favorable impact on the survival of mBC patient
Publikováno v:
Tumori Journal. 101:424-432
Aims and Background First-line chemotherapies for advanced non-small-cell lung cancer (NSCLC) are platinum-based regimens. An analysis of efficacy outcomes has not yet been systematically performed and fully evaluated using large patient cohorts in e
Autor:
Diego Serraino, Valentina Rosato, Carlo La Vecchia, Eva Negri, Luigino Dal Maso, Maurizio Montella, Cristina Bosetti
Publikováno v:
Tumori Journal. 102:252-257
Background Scanty data exist on the role of personal medical conditions, except for gallstones, and family history of cancer on the risk of biliary tract cancers (BTC). Methods We analyzed this issue using data from two Italian case-control studies,
Autor:
Elisabetta Perrucci, Manuela Margaritelli, Alessia Farneti, Valentina Lancellotta, Cynthia Aristei, Isabella Palumbo, Vittorio Bini, Lorenzo Falcinelli, Giorgia Capezzali
Publikováno v:
Tumori Journal. 101:161-167
Aim and Background Conservative surgery and radiotherapy for early breast cancer offers a better quality of life than mastectomy. As 80–85% of breast relapses develop close to the tumour bed, partial breast irradiation was developed to overcome dra
Publikováno v:
Tumori Journal. 101:194-198
Aim CSE1L is the human homologue to the yeast gene CSE1 and CSE1L is a gene related to cancer progression. Thus, CSE1L may regulate the invasion and metastasis of breast cancer. The aim of this study is to show the relationship between CSE1L and axil
Autor:
Lorenza Rimassa, Armando Santoro, Antonio Gasbarrini, Bruno Daniele, Camillo Porta, Domenico Germano, Maria Lamar, Stefania Salvagni, Terri Goldberg, Gianluca Masi, Giovanni Abbadessa
Publikováno v:
Tumori Journal. 101:139-143
In the last decades the management of hepatocellular carcinoma (HCC) has undergone significant changes following the introduction of novel therapies such as sorafenib, which have improved patient survival. Nevertheless, HCC is still the third most co
Autor:
Ugo Pastorino, Paolo Pozzi, Francesca Bravi, Elena Munarini, Marta Rossi, Roberto Boffi, Carlo La Vecchia
Publikováno v:
Tumori Journal. 101:306-311
Aims and Background The time of lung cancer screening may provide the ideal setting to discuss and initiate a smoking cessation plan that includes pharmacologic aids. No studies to date have fully investigated the potential effectiveness of such comb
Autor:
Renata Kelly Kuniyoshi, Ligia Ajaime Azzalis, Virginia Junqueira, Carolina M Bonaldi, Claudia Giorgia Bronzatti de Oliveira, Thaís Moura Gascón, Fernando Luiz Affonso Fonseca, Viviane Aparecida Vilas Boas, Flávia de Sousa Gehrke, Beatriz da Costa Aguiar Alves
Publikováno v:
Tumori Journal. 101:185-188
Aims and Background Prostate cancer is the most common malignant tumor in men. Serum prostate-specific antigen (PSA), Gleason score and clinical range at the time of diagnosis are important factors to predict prognosis and outcome after therapy but a
Publikováno v:
Tumori Journal. 101:30-35
Background Elderly patients with metastatic breast cancer (MBC) have more problems receiving chemotherapy than younger patients, especially with the presence of multiple comorbidities, adverse drug events and functional decline. Low-dose oral adminis
Autor:
Barbara Vischioni, Barbara Alicja Jereczek-Fossa, Cristiana Fodor, Maria Cristina Leonardi, Annamaria Ferrari, Veronica Dell’Acqua, Alessandra Balduzzi, Marco Colleoni, Alberto Luini, Giovanni Ivaldi, Luigi Santoro, Roberto Orecchia, Carlo M. Cipolla, Daniela Cardinale, Anna Morra
Publikováno v:
Tumori Journal. 101:64-71
Purpose To evaluate the tolerance of concomitant administration of anthracycline-based chemotherapy (CHT) and 3-dimensional conformal radiotherapy (RT) after breast-conserving surgery. Methods and Materials Sixty-seven patients, treated with conserva